Skip to main content

Cerebrovascular Diseases: Post-stroke Depression and Anhedonia

  • Chapter
  • First Online:
Anhedonia: A Comprehensive Handbook Volume II

Abstract

Increasing interest in depression within acute and chronic cerebrovascular pathology is justified for its clinical relevance, since its identification and management is of use in reducing disability, the caregiver’s burden and the social-economic impact of cerebrovascular disease. Anhedonia, or markedly diminished interest or pleasure, is a hallmark symptom of major depression, schizophrenia and other neuropsychiatric disorders, including cerebrovascular disorders. Since stroke survivors frequently suffer from depression, research has focused on the incidence, phenomenology, course and risk factors of post-stroke depression (PSD), paying special attention to the biological explanatory models, such as the lesion location and vascular depression hypotheses. Small vessel pathology and microvascular lesions are no longer considered as minor players in the fields of cognitive impairment and mood regulation. Unlike cognition, the relationship between these lesions and mood dysregulation is still a matter of intense debate. However, the chronic accumulation of lacunes in thalamus, basal ganglia and deep white matter has been recently considered as a strong correlate of PSD.

In addition to such biological approaches, the role of psychosocial factors should not be neglected. This chapter is aimed at investigating the complex relationship between depressive mood and cerebrovascular disorders, either acute or chronic, with particular regards to the etiology and prevalence of the disabling symptom anhedonia in PSD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

NIHSS:

National Institute of Health Stroke Scale

Qol:

Quality of life

CVD:

Cerebrovascular Disease

LA:

Leukoaraiosis

WMH:

White matter hyperhintesities

LADIS:

Leukoaraiosis and Disability in the Elderly Study

MRI:

Magnetic resonance imaging

VAD:

Vascular Depression

PST:

Problem-solving therapy

PSD:

Post stroke depression

DSMIVTR:

Diagnostic and statistical manual of mental disorders: Fourth Edition Text Revision

ICD-10:

International statistical classification of diseases and related health problems 10TH edition

PSDS:

Post Stroke Depression Scale

VMPFC:

Ventromedial prefrontal cortex

References

  1. Lyden P, Lu M, Jackson C, Marler J, et al. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke. 1999;30(11):2347–54.

    Article  CAS  PubMed  Google Scholar 

  2. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.

    Article  PubMed  Google Scholar 

  3. Dennis MS, Burn JP, Sandercock PA, et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24(6):796–800.

    Article  CAS  PubMed  Google Scholar 

  4. Pantoni L. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. Stroke. 2008;39(5):1401–3.

    Article  PubMed  Google Scholar 

  5. Pantoni L, Poggesi A, Basile AM, et al. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc. 2006;54(7):1095–101.

    Article  PubMed  Google Scholar 

  6. Teodorczuk A, Firbank MJ, Pantoni L, LADIS Group, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40:603–10.

    Article  CAS  PubMed  Google Scholar 

  7. Firbank MJ, Teodorczuk A, van der Flier WM, LADIS Group, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry. 2012;201:40–5.

    Article  PubMed  Google Scholar 

  8. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke. 1999;30(10):2159–66.

    Article  CAS  PubMed  Google Scholar 

  9. Kumar A, Bilker W, Lavretsky H, Gottlieb G. Volumetric asymmetries in late-onset mood disorders: an attenuation of frontal asymmetry with depression severity. Psychiatry Res. 2000;100(1):41–7.

    Article  CAS  PubMed  Google Scholar 

  10. Firbank MJ, Lloyd AJ, Ferrier N, O’Brien JT. A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry. 2004;12(6):606–12.

    Article  PubMed  Google Scholar 

  11. Hannestad J, Taylor WD, McQuoid DR, et al. White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatry. 2006;21(12):1193–8.

    Article  PubMed  Google Scholar 

  12. Janssen J, Hulshoff Pol HE, de Leeuw FE, et al. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. Neurol Neurosurg Psychiatry. 2007;78(6):638–40.

    Article  Google Scholar 

  13. Verdelho A, Madureira S, Moleiro C, et al. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry. 2013;84:1250–4. doi:10.1136/jnnp-2012-304191.

    Article  PubMed  Google Scholar 

  14. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry. 1997;154(4):562–5.

    CAS  PubMed  Google Scholar 

  15. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154(4):497–501.

    CAS  PubMed  Google Scholar 

  16. Krishnan KR, McDonald WM. Arteriosclerotic depression. Med Hypotheses. 1995;44(2):111–5.

    Article  CAS  PubMed  Google Scholar 

  17. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry. 2006;60(12):1304–5.

    Article  PubMed  Google Scholar 

  18. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43(10):705–12.

    Article  CAS  PubMed  Google Scholar 

  19. Alexopoulos GS. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry. 2002;10(6):687–95.

    Article  PubMed  Google Scholar 

  20. Eaton WW, Kalaydjian A, Scharfstein DO, et al. Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981–2004. Acta Psychiatr Scand. 2007;116(3):182–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Krishnan KR, Taylor WD, McQuoid DR, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry. 2004;55(4):390–7.

    Article  PubMed  Google Scholar 

  22. Hickie I, Scott E, Mitchell P, et al. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37(3):151–60.

    Article  CAS  PubMed  Google Scholar 

  23. Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry. 2006;18(5):433–41.

    Article  PubMed  Google Scholar 

  24. Miller JM, Vorel SR, Tranguch AJ, et al. Anhedonia after a selective bilateral lesion of the globus pallidus. Am J Psychiatry. 2006;163(5):786–8.

    Article  PubMed  Google Scholar 

  25. Steffens DC, Krishnan KR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33(6):1636–44.

    Article  PubMed  Google Scholar 

  26. Thomas AJ, Perry R, Barber R, et al. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci. 2002;977:333–9.

    Article  PubMed  Google Scholar 

  27. Kramer-Ginsberg E, Greenwald BS, Krishnan KR, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156(3):438–44.

    CAS  PubMed  Google Scholar 

  28. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961–70.

    Article  PubMed  Google Scholar 

  29. Kales HC, Maixner DF, Mellow AM. Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry. 2005;13(2):88–98.

    Article  PubMed  Google Scholar 

  30. Naarding P, Veereschild M, Bremmer M, et al. The symptom profile of vascular depression. Int J Geriatr Psychiatry. 2009;24(9):965–9.

    Article  PubMed  Google Scholar 

  31. De Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57(11):1071–6.

    Article  PubMed  Google Scholar 

  32. Taylor WD, Steffens DC, MacFall JR, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60(11):1090–6.

    Article  PubMed  Google Scholar 

  33. Alexopoulos GS, Raue P, Areán P. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry. 2003;11(1):46–52.

    Article  PubMed  Google Scholar 

  34. Levy RM, Steffens DC, McQuoid DR, et al. MRI lesion severity and mortality in geriatric depression. Am J Geriatr Psychiatry. 2003;11(6):678–82.

    Article  PubMed  Google Scholar 

  35. Fischer CE, Jiang D, Schweizer TA. Determining the association of medical co-morbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review. BMC Geriatr. 2010;10:89. Available at: http://www.biomedcentral.com/1471-2318/10/89/

  36. Baldwin RC. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int J Geriatr Psychiatry. 2005;20(1):1–11.

    Article  PubMed  Google Scholar 

  37. Santos M, Kövari E, Gold G, et al. The neuroanatomical model of post-stroke depression: towards a change of focus? J Neurol Sci. 2009;283(1–2):158–62.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Sheline YI, Pieper CF, Barch DM, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67(3):277–85.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963–74. doi:10.1038/mp.2013.20.

    Article  CAS  PubMed  Google Scholar 

  40. Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord. 2004;79(1–3):81–95.

    Article  PubMed  Google Scholar 

  41. Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry. 2002;52(3):253–64.

    Article  PubMed  Google Scholar 

  42. Dieguez S, Staub F, Bruggimann L, et al. Is poststroke depression a vascular depression? J Neurol Sci. 2004;226(1–2):53–8.

    Article  PubMed  Google Scholar 

  43. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: Fourth Edition Text Revision DSM-IV-TR®. Washington, DC: American Psychiatric Association; 2000.

    Book  Google Scholar 

  44. Gordon WA, Hibbard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil. 1997;78(6):658–63.

    Article  CAS  PubMed  Google Scholar 

  45. Spencer KA, Tompkins CA, Schulz R. Assessment of depression in patients with brain pathology: the case of stroke. Psychol Bull. 1997;122(2):132–52.

    Article  CAS  PubMed  Google Scholar 

  46. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54(3):376–87.

    Article  PubMed  Google Scholar 

  47. De Wit L, Putman K, Baert I, et al. Anxiety and depression in the first six months after stroke. A longitudinal multicentre study. Disabil Rehabil. 2008;30(24):1858–66.

    Article  PubMed  Google Scholar 

  48. Srivastava A, Taly AB, Gupta A, Murali T. Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol. 2010;13(2):123–7.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Poynter B, Shuman M, Diaz-Granados N, et al. Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics. 2009;50(6):563–9.

    Article  PubMed  Google Scholar 

  50. Pohjasvaara T, Vataja R, Leppävuori A, et al. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol. 2001;8(4):315–9.

    Article  CAS  PubMed  Google Scholar 

  51. Paolucci S, Gandolfo C, Provinciali L, et al. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253(5):556–62.

    Article  PubMed  Google Scholar 

  52. Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry. 2010;55(6):341–9.

    PubMed Central  PubMed  Google Scholar 

  53. Sibon I, Lassalle-Lagadec S, Renou P, et al. Evolution of depression symptoms following stroke: a prospective study using computerized ambulatory monitoring. Cerebrovasc Dis. 2012;33(3):280–5.

    Article  PubMed  Google Scholar 

  54. Beblo T, Wallesch CW, Herrmann M. The crucial role of frontostriatal circuits for depressive disorders in the postacute stage after stroke. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(4):236–46.

    CAS  PubMed  Google Scholar 

  55. Starkstein SE, Bryer JB, Berthier ML, et al. Depression after stroke: the importance of cerebral hemisphere asymmetries. J Neuropsychiatry Clin Neurosci. 1991;3(3):276–85.

    CAS  PubMed  Google Scholar 

  56. Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry. 1989;154:170–82.

    Article  CAS  PubMed  Google Scholar 

  57. Fang J, Cheng Q. Etiological mechanisms of post-stroke depression: a review. Neurol Res. 2009;31(9):904–9.

    Article  PubMed  Google Scholar 

  58. Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients. Importance of location of lesion. Brain. 1984;107(1):81–93.

    Article  PubMed  Google Scholar 

  59. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain. 1987;110(4):1045–59.

    Article  PubMed  Google Scholar 

  60. Narushima K, Kosier JT, Robinson RG. A reappraisal of post-stroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci. 2003;15(4):422–30.

    Article  CAS  PubMed  Google Scholar 

  61. Agrell B, Dehlin O. Depression in stroke patients with left and right hemisphere lesions. A study in geriatric rehabilitation in-patients. Aging. 1994;6(1):49–56.

    CAS  PubMed  Google Scholar 

  62. Altieri M, Maestrini I, Mercurio A, et al. Depression after minor stroke: prevalence and predictors. Eur J Neurol. 2012;19(3):517–21.

    Article  CAS  PubMed  Google Scholar 

  63. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163–7.

    Article  CAS  PubMed  Google Scholar 

  64. House A. Depression associated with stroke. Neuropsychiatry Clin Neurosci. 1996;8(4):453–7.

    CAS  Google Scholar 

  65. da Rocha e Silva CE, Alves Brasil MA, Matos do Nascimento E, et al. Is poststroke depression a major depression? Cerebrovasc Dis. 2013;35(4):385–91.

    Article  PubMed  Google Scholar 

  66. Farner L, Wagle J, Engedal K, et al. Depressive symptoms in stroke patients: a 13 month follow-up study of patients referred to a rehabilitation unit. J Affect Disord. 2010;127(1–3):211–8.

    Article  PubMed  Google Scholar 

  67. Berg A, Palomäki H, Lehtihalmes M. Poststroke depression: an 18-month follow-up. Stroke. 2003;34(1):138–43.

    Article  PubMed  Google Scholar 

  68. Gainotti G, Azzoni A, Razzano C, et al. The Post-Stroke Depression Rating Scale: a test specifically devised to investigate affective disorders of stroke patients. J Clin Exp Neuropsychol. 1997;19(3):340–56.

    Article  CAS  PubMed  Google Scholar 

  69. Calabrò RS, Italiano D, Militi D, et al. Levetiracetam-associated loss of libido and anhedonia. Epilepsy Behav. 2012;24(2):283–4.

    Article  PubMed  Google Scholar 

  70. Haslam J. Observations on madness and melancholy; including practical remarks on those diseases, together with cases, and an account of the morbid appearances on dissection. London: Callow; 1809.

    Google Scholar 

  71. Ribot T. La Psychologie des Sentiments. Paris: F. Alcan; 1896.

    Google Scholar 

  72. World Health Organization. ICD-10: international statistical classification of diseases and related health problems. 10th ed. Geneva: World Health Organization; 2004.

    Google Scholar 

  73. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–55.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35(1):68–77.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  75. Ho N, Sommers M. Anhedonia: a concept analysis. Arch Psychiatr Nurs. 2013;27(3):121–9.

    Article  PubMed  Google Scholar 

  76. Cohen AS, Najolia GM, Brown LA, Minor KS. The state-trait disjunction of anhedonia in schizophrenia: potential affective, cognitive and social-based mechanisms. Clin Psychol Rev. 2011;31(3):440–8.

    Article  PubMed  Google Scholar 

  77. Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. Am J Psychiatry. 2012;169(4):364–73.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Komulainen T, Keränen AM, Rasinaho E, et al. Quitting a weight loss program is associated with anhedonia: preliminary findings of the Lifestyle Intervention Treatment Evaluation Study in northern Finland. Int J Circumpolar Health. 2011;70(1):72–8.

    Article  PubMed  Google Scholar 

  79. Cohen AS, Callaway DA, Najolia GM, et al. On “risk” and reward: investigating state anhedonia in psychometrically defined schizotypy and schizophrenia. J Abnorm Psychol. 2012;121(2):407–15.

    Article  PubMed  Google Scholar 

  80. Cohen AS, Couture SM, Blanchard JJ. Neuropsychological functioning and social anhedonia: three-year follow-up data from a longitudinal community high risk study. J Psychiatr Res. 2012;46(7):898–904.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Lee JS, Park HJ, Chun JW, et al. Neuroanatomical correlates of trait anhedonia in patients with schizophrenia: a voxel-based morphometric study. Neurosci Lett. 2011;489(2):110–4.

    Article  CAS  PubMed  Google Scholar 

  82. Steer RA. Self-reported inability to cry as a symptom of anhedonic depression in outpatients with a major depressive disorder. Psychol Rep. 2011;108(3):874–82.

    Article  PubMed  Google Scholar 

  83. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28(3):309–69.

    Article  CAS  PubMed  Google Scholar 

  84. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36(2):241–63.

    Article  CAS  PubMed  Google Scholar 

  85. Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res. 2008;14(2–3):169–83.

    Article  PubMed Central  PubMed  Google Scholar 

  86. Carver CS. Affect and the functional bases of behavior: on the dimensional structure of affective experience. Personal Soc Psychol Rev. 2001;5(4):345–56.

    Article  Google Scholar 

  87. Dickinson A, Balleine B. Motivational control of instrumental action. Curr Dir Psychol Sci. 1995;4(5):162–7.

    Article  Google Scholar 

  88. Gard DE, Kring AM, Gard MG, et al. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93(1–3):253–60.

    Article  PubMed Central  PubMed  Google Scholar 

  89. Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008;10(3):291–9.

    PubMed Central  PubMed  Google Scholar 

  90. Harvey PO, Pruessner J, Czechowska Y, et al. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Mol Psychiatry. 2007;12:703. 767–775.

    Article  PubMed  Google Scholar 

  91. Keedwell PA, Andrew C, Williams SC, et al. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005;58(11):843–53.

    Article  PubMed  Google Scholar 

  92. Bartoli F, Lillia N, Lax A, et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat. 2013;2013:862978.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rocco Salvatore Calabrò .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Calabrò, R.S., Spadaro, L., Bramanti, P. (2014). Cerebrovascular Diseases: Post-stroke Depression and Anhedonia. In: Ritsner, M. (eds) Anhedonia: A Comprehensive Handbook Volume II. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-8610-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-8610-2_15

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-8609-6

  • Online ISBN: 978-94-017-8610-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics